ANTITHYROID HORMONE ANTIBODIES INDUCED BY INTERFERON-ALPHA

被引:27
作者
PAPO, T
OKSENHENDLER, E
ZEMBART, M
LEGER, A
CLAUVEL, JP
机构
[1] HOP ST LOUIS, SERV IMMUNOPATHOL & HEMATOL, 1 AVE CLAUDE VELLEFAUX, F-75010 PARIS, FRANCE
[2] HOP NECKER ENFANTS MALAD, SERV CENT RADIOISOTOPES, F-75743 PARIS 15, FRANCE
关键词
D O I
10.1210/jc.75.6.1484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 40-yr-old woman known for a multinodular goiter had hyperthyroidism. Treatment with antithyroid drugs and iodine therapy was effective. One year later, she received interferon-alpha for treatment of essential cryoglobulinemia. At that time, the patient was euthyroid. Testing for antithyroglobulin, antimicrosome, anti-TSH receptor, and antithyroid hormone antibodies was negative. After a 1-yr course of interferon-alpha, goiter enlargement was noticed. Apparently elevated free T3 and T4 serum values were measured by RIA, contrasting with clinical euthyroidism and normal TSH values. High serum levels of antithyroid hormone antibodies were found in the patient's serum, using a radio-labeled hormone immunoprecipitation assay. Antithyroglobulin and antimicrosome antibodies titers were also elevated and paralleled antithyroid hormone antibodies. After cessation of interferon-alpha therapy, clinical status and TSH levels remained normal, while thyroid hormone values and antithyroid hormone antibody levels progressively normalized. To our knowledge, this is the first report of antithyroid hormone antibodies induced by interferon-alpha. Since thyroid dysfunction is described in 10-15% of treated patients, the fact that interferon-alpha can induce antithyroid hormone antibodies has important implications: 1) the prevalence or intensity of thyroid dysfunction could be overestimated; and 2) artifactually elevated free T3 and T4 serum values could lead to inappropriate therapy of thyroid disease or cessation of interferon treatment.
引用
收藏
页码:1484 / 1486
页数:3
相关论文
共 23 条
[1]  
ALLAN DJ, 1982, LANCET, V2, P824
[2]   CIRCULATING THYROID-HORMONE AUTOANTIBODIES [J].
BENVENGA, S ;
TRIMARCHI, F ;
ROBBINS, J .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (06) :605-619
[3]  
BONOMO L, 1988, LANCET, V2, P274
[4]   THYROID AUTOIMMUNITY IN PATIENTS ON LONG-TERM THERAPY WITH LEUKOCYTE-DERIVED INTERFERON [J].
BURMAN, P ;
TOTTERMAN, TH ;
OBERG, K ;
KARLSSON, FA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (05) :1086-1090
[5]   RECOMBINANT INTERFERON-ALPHA CAN INDUCE REARRANGEMENT OF T-CELL ANTIGEN RECEPTOR ALPHA-CHAIN GENES AND MATURATION TO CYTOTOXICITY IN T-LYMPHOCYTE CLONES INVITRO [J].
CHEN, LK ;
MATHIEUMAHUL, D ;
BACH, FH ;
DAUSSET, J ;
BENSUSSAN, A ;
SASPORTES, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4887-4889
[6]   MONOCLONAL TRIIODOTHYRONINE (T3)-BINDING IMMUNOGLOBULINS IN A EUTHYROID WOMAN [J].
DEBAETS, M ;
SELS, J ;
VRIESMAN, PV ;
ELEWAUT, A ;
VERMEULEN, A ;
WILLEMS, P ;
COENEGRACHT, J .
CLINICA CHIMICA ACTA, 1982, 118 (2-3) :293-301
[7]   UNUSUAL MANIFESTATIONS OF MONOCLONAL GAMMOPATHIES - AUTOIMMUNE AND IDIOPATHIC SYNDROMES [J].
DUGGAN, DB ;
SCHATTNER, A .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (05) :864-870
[8]  
FENTIMAN IS, 1985, LANCET, V1, P1166
[9]   AN AUTOIMMUNE ETIOLOGY FOR HYPOTHYROIDISM FOLLOWING INTERFERON THERAPY FOR BREAST-CANCER [J].
FENTIMAN, IS ;
BALKWILL, FR ;
THOMAS, BS ;
RUSSELL, MJ ;
TODD, I ;
BOTTAZZO, GF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08) :1299-1303
[10]  
FRIEDMAN DF, 1991, J EXP MED, V174, P252